Stockscreener 앱 받기
0.2842
0.25%
-0.0007
시간 외 거래:
.29
0.0058
+2.04%
Shuttle Pharmaceuticals Holdings Inc 주식(SHPH)의 최신 뉴스
Did Shuttle Pharmaceuticals Holdings Inc (SHPH) perform well in the last session? - uspostnews.com
Market Resilience: Shuttle Pharmaceuticals Holdings Inc (SHPH) Finishes Weak at 0.27, Down -8.74 - DWinneX
Nothing is Better Than Shuttle Pharmaceuticals Holdings Inc (SHPH) stock at the moment - Sete News
Shuttle Pharmaceuticals Holdings Inc [SHPH] moved up 0.12: Why It’s Important - dbtnews.com
Ratio Revelations: Shuttle Pharmaceuticals Holdings Inc (SHPH)’s Financial Metrics in the Spotlight - DWinneX
Small Cap Stock Shuttle Pharmaceuticals Holdings Inc (SHPH) Is A Buy – Analysts - Marketing Sentinel
The Psychology of Shuttle Pharmaceuticals Holdings Inc Inc. (SHPH) Price Performance: Understanding Market Sentiment - investchronicle.com
A review of SHPH’s current quarter earnings predictions - uspostnews.com
Shuttle Pharma to Present at the Planet MicroCap Showcase: VEGAS 2025 on April 23, 2025 - GlobeNewswire
Shuttle Pharma's Latest Glioblastoma Trial Data and Cancer Diagnostic Advances: Key Updates Coming April 23 - Stock Titan
Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ:SHPH) Sees Significant Growth in Short Interest - Defense World
Shuttle Pharmaceuticals (NASDAQ:SHPH) Trading Down 16.7% – Here’s Why - Defense World
SHPH stock plunges to 52-week low of $0.33 amid steep annual decline - Investing.com India
Shuttle Pharma files patent for cancer treatment innovation By Investing.com - Investing.com Canada
Shuttle Pharmaceuticals Files Provisional US Patent to Treat Prostrate Cancer - marketscreener.com
Shuttle Pharma files patent for cancer treatment innovation - Investing.com Australia
Shuttle Pharmaceuticals Files Provisional Patent Application For PSMA Ligand Conjugates To Treat Prostate Cancer - marketscreener.com
Shuttle Pharma Developing Pretreatment Diagnostic Blood - GlobeNewswire
Game-Changing Prostate Cancer Treatment: Shuttle Pharma Unveils Breakthrough PSMA Technology - Stock Titan
Head to Head Analysis: Shuttle Pharmaceuticals (NASDAQ:SHPH) vs. Phibro Animal Health (NASDAQ:PAHC) - Defense World
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
Shuttle Pharmaceuticals to Present at the Emerging Growth Conference on December 7, 2023 - Seeking Alpha
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
Shuttle Pharmaceuticals Appoints New Interim CEO and CSO - TipRanks
Shuttle Pharmaceuticals signs consulting deal with Bowery Group By Investing.com - Investing.com Australia
Shuttle Pharmaceuticals signs consulting deal with Bowery Group - Investing.com
Shuttle Pharmaceuticals Holdings IncOn March 21, Enters Consulting Agreement With Bowery ConsultingSEC Filing - Marketscreener.com
Growth Stocks Are Beaten Down. Why It’s Temporary and What Should Be On Your Shopping List Instead - Asianet Newsable
Shuttle Pharmaceuticals (NASDAQ:SHPH) Stock Price Up 3.8% – Should You Buy? - Defense World
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
SHPH stock touches 52-week low at $0.34 amid market challenges - Investing.com
SHPH stock touches 52-week low at $0.34 amid market challenges By Investing.com - Investing.com South Africa
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
SHPHSHUTTLE PHARMACTCLS HLDGS INC Latest Stock News & Market Updates - Stock Titan
Shuttle Pharma Announces Closing Of $5.75 Million Underwritten Offering -March 13, 2025 at 05:39 pm EDT - Marketscreener.com
Shuttle Pharma Secures $5.2M in Public Offering - TipRanks
Shuttle Pharma Announces Closing of $5.75 Million Underwritten Offering - GlobeNewswire
Shuttle Pharma Announces Closing of $5.75 Million Underwritten Offering - Benzinga
Shuttle Pharma Raises $5.75M: Strategic Boost for Revolutionary Cancer Treatment Trial - StockTitan
Shuttle Pharmaceuticals Holdings, Inc. Closes $5.75 Million Public Offering to Fund Phase II Clinical Trial - Nasdaq
Shuttle Pharma appoints new interim co-CEO By Investing.com - Investing.com Australia
This Md. biotech wants to get a cancer treatment to patients. It just tapped an industry outsider as co-CEO. - The Business Journals
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
Shuttle Pharma announces $5.75 million stock offering - Investing.com India
Shuttle Pharma announces $5.75 million stock offering By Investing.com - Investing.com Canada
Shuttle Pharma Announces Pricing of $5.75 Million Underwritten Offering -March 12, 2025 at 09:25 am EDT - Marketscreener.com
Shuttle Pharma Announces Pricing of $5.75 Million Underwritten Offering - GlobeNewswire
Shuttle Pharma Secures Critical $5.75M Funding for Revolutionary Cancer Radiation Therapy - StockTitan
4 Artificial Intelligence (AI) Stocks Worth Buying in the Tech Sell-Off - The Globe and Mail
1.20%
0.06%
자본화:
|
볼륨(24시간):